Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-09-24
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, A61K 3144, C07D41904
Patent
active
055591388
ABSTRACT:
This invention relates to the treatment of glaucoma by topically administering a compound selected among ##STR1## wherein Z, R, and R.sup.1 are defined in the specification, and a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4837241 (1989-06-01), Jensen
patent: 4866077 (1989-09-01), Bogeso et al.
patent: 4933353 (1990-06-01), Jenssen
patent: 4952587 (1990-08-01), Baker et al.
patent: 5017618 (1991-05-01), Border
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
patent: 5175166 (1992-12-01), Dunbar
Tune et al. "Anticolinergic delirium caused by topical homatropine ophthalmologic solution" Index Medicus 330504 (1992).
Sugrue "The pharmacology of antiglaucoma drugs" Pharm. Ther. v. 43, pp. 91-138 (1989).
Bodor et al. "Improved delivery through biological membrane" J. Med. Chem. v. 31, pp. 100-106 (1988).
Wilbraham et al. "Organic and biological chemistry" The Benjamin/Cummins Pub. pp. 266-269 (1985).
Olesen Preben H.
Sauerberg Per
Chang Ceila
Lambiris Elias J.
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Te does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Te, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Te will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928702